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Risk factors for Epstein Barr virus-associated 
cancers: a systematic review, critical appraisal, 
and mapping of the epidemiological evidence
Background Epstein Barr Virus (EBV) infects 90%-95% of all adults glob-
ally and causes ~ 1% of all cancers. Differing proportions of Burkitt’s lym-
phoma (BL), gastric carcinoma (GC), Hodgkin’s lymphoma (HL) and na-
sopharyngeal carcinoma (NPC) are associated with EBV. We sought to 
systematically review the global epidemiological evidence for risk factors 
that (in addition to EBV) contribute to the development of the EBV-as-
sociated forms of these cancers, assess the quality of the evidence, and 
compare and contrast the cancers.
Methods MEDLINE, Embase and Web of Science were searched for stud-
ies of risk factors for EBV-associated BL, GC, HL and NPC without lan-
guage or temporal restrictions. Studies were excluded if there was no 
cancer-free comparator group or where analyses of risk factors were in-
adequately documented. After screening and reference list searching, data 
were extracted into standardised spreadsheets and quality assessed. Due 
to heterogeneity, a narrative synthesis was undertaken.
Results 9916 hits were retrieved. 271 papers were retained: two BL, 24 
HL, one GC and 244 NPC. The majority of studies were from China, 
North America and Western Europe. Risk factors were categorised as di-
etary, environmental/non-dietary, human genetic, and infection and clin-
ical. Anti-EBV antibody load was associated with EBV-associated GC and 
BL. Although the evidence could be inconsistent, HLA-A alleles, smok-
ing, infectious mononucleosis and potentially other infections were risk 
factors for EBV-associated HL. Rancid dairy products; anti-EBV antibody 
and EBV DNA load; history of chronic ear, nose and/or throat conditions; 
herbal medicine use; family history; and human genetics were risk factors 
for NPC. Fresh fruit and vegetable and tea consumption may be protec-
tive against NPC.
Conclusions Many epidemiological studies of risk factors in addition to 
EBV for the EBV-associated forms of BL, GC, HL and NPC have been un-
dertaken, but there is a dearth of evidence for GC and BL. Available evi-
dence is of variable quality. The aetiology of EBV-associated cancers like-
ly results from a complex intersection of genetic, clinical, environmental 
and dietary factors, which is difficult to assess with observational studies. 
Large, carefully designed, studies need to be strategically undertaken to 
harmonise and clarify the evidence.
Registration PROSPERO CRD42017059806.
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Epstein Barr Virus (EBV) is a herpesvirus estimated to infect 90%-95% of all humans [1]. Infection is 
lifelong and in low-income settings occurs in childhood; in higher income settings it may also occur in 
childhood but is often delayed until late adolescence or adulthood. In a minority of people infection is as-
sociated with the development of cancer [2]. Indeed, Epstein, Achong and Barr’s work describing the pres-
ence of EBV in a cultured Burkitt’s lymphoma (BL) cell line was the scientific foundation implicating the 
first known human tumour virus [3]. EBV is now associated with 1% of global cancers, which are mostly 
lymphomas and carcinomas; approximately 140 000 people die of EBV-associated cancers each year [4,5].
Despite decades of intensive research, the aetiology of EBV-linked cancers remains unclear. As only a frac-
tion of EBV-infected individuals develop cancer, other factors must also be influential. Several reviews have 
been undertaken of the biological and epidemiological evidence for the association between EBV and dif-
ferent cancers [5-16], but none have systematically collated the epidemiological evidence for additional 
risk factors beyond EBV infection, or assessed the quality of the presented evidence. Pragmatically, such 
an undertaking requires a focus on a small number of contrasting cancer types that have strong evidence 
of a causal relationship with EBV, are of significant burden and/or have globally disparate distributions, 
such as BL, Hodgkin’s lymphoma (HL), gastric carcinoma (GC), and nasopharyngeal carcinoma (NPC).
In 2016, there were approximately 461 000 incident cases of non-Hodgkin’s lymphoma (NHL) global-
ly [17]. BL is a highly aggressive and fast-growing NHL classified in three forms: endemic, sporadic and 
AIDS-associated [5]. The endemic form is thought to have EBV present in more than 95% of tumours; 
this decreases to 15%-88% for sporadic tumours and 30%-40% for those that are AIDS-associated [5]. 
Endemic BL is generally a paediatric condition of the jaw found in equatorial Africa and Papua New 
Guinea which has been strongly linked to malaria [5]. Sporadic BL is associated largely with white pop-
ulations, across a wider age range and disease of the abdomen [5]. All types of BL are more common in 
males than females [5].
HL is a lymphoma characterised by the presence of Hodgkin and Reed-Sternberg cells which has various 
histological appearances. There were an estimated 73 000 incident cases globally in 2016 [17]. 40%-50% 
are thought to be associated with EBV, but the degree of association is highly population-dependent; EBV 
positive HL as a percentage of all HL is highest (90%-100%) in lower income countries [18-20]. Incidence 
rates of this form of cancer peak in children and individuals over 70 years of age, are more common in 
non-white ethnic groups, and in males than females [5].
With 830 000 deaths and 1.2 million cases globally (2016), GC is a major cause of morbidity and mor-
tality [17]. Around 95% of GC is gastric adenocarcinoma; approximately 10% of this is EBV-associated, 
with variation between populations [5]. Due to the commonality of GC, EBV-associated GC is likely to 
be the most common EBV-associated malignancy, but is poorly studied [5]. The cancer is associated with 
being male; for men prevalence decreases with age [21].
96 000 cases of cancer of the nasopharynx occurred in 2016 [17]. NPC forms the majority of this burden 
and occurs in the epithelial cells of the nasopharynx. Tumours are classified depending upon the level 
of differentiation in these cells: type I (squamous), type II (non-keratinising), type III (undifferentiated). 
EBV is strongly associated with types II and III and more controversially with type I [22]. NPC incidence 
is geographically extremely variable, with the disease associated with northern Africa and southeast Asia, 
particularly southern China and East Malaysia [5]. The disease is more common in males; age associa-
tions vary between settings.
Given the global importance of EBV-associated BL, HL, GC and NPC, their contrasting features yet com-
mon link with EBV, and their complex but unclear aetiology, we undertook a systematic review to map 
the current global epidemiological evidence base of risk factors for the EBV-associated forms of these tu-
mours in addition to EBV itself. We present an evaluative narrative summary of that evidence, a quality 
assessment, and an appraisal of the critical gaps in the literature.
METHODS
Search strategy
MEDLINE (United States National Library of Medicine, Bethesda MD, United States of America; through 
Ovid [Wolter Kluwer, Alphen aan den Rijn, The Netherlands]), Embase (Elsevier, Amsterdam, The Neth-
erlands; through Ovid) and the Web of Science (Clarivate Analytics, Philadelphia, PA, United States of 
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America) were searched for studies of risk factors for a) EBV-associated HL and BL and b) EBV-associated 
NPC and GC in addition to EBV in June to August 2017 (Appendix S1 in the Online Supplementary 
Document). Search strategies were compiled for MEDLINE and then adapted for the other databases. 
Reference lists of included papers and review articles were also searched (‘snowballing’). This review was 
registered on PROSPERO as CRD42017059806.
Study selection
Inclusion criteria:
•  Epidemiological studies (observational and interventional) of risk factors for EBV-associated HL, BL, 
NPC and/or GC with extractable data and a cancer-free comparator population.
• Human studies.
• No date restrictions.
• No population restrictions.
• No language restrictions.
Exclusion criteria:
• Animal studies.
• Studies of risk factors for EBV infection, not EBV-associated cancers.
•  Studies where the tumours were not proven to be EBV positive, unless for NPC, where EBV is thought 
to be associated with 95% of tumours [23].
•  Comparator population had cancer or pre-cancerous lesions (including both EBV-negative HL/BL/
GC/NPC and other forms of cancer).
•  Gene/protein expression or genetic (human or EBV) studies of samples taken from cancer tissues, 
due to the potential for post-tumour mutations.
•  Genetics studies where samples were taken from different bodily sites for the cancer and compar-
ator groups.
•  EBV genetic and anti-EBV antibody expression studies where samples were taken cross-sectionally 
from cancer patients, due to the potential for tumour-induced expression, or where antibody load 
was not documented.
Hits were screened at the title, abstract and full text stages by three reviewers per cancer, with at least a 
10% overlap. Disagreements were resolved by an independent reviewer. Data extraction was undertak-
en by the same three reviewers, with at least 10% overlap. Discrepancies were resolved by consensus.
Data extraction
Data were extracted into a pre-designed spreadsheet which included data on the study design, popula-
tion and risk factors assessed for EBV-associated cancers.
Quality assessment
The quality of included studies was assessed using a checklist adapted from Downs and Black [24], as 
per the guidance issued by Deeks et al. [25]. Quality assessment was made for the main risk factor(s) of 
interest; if multiple risk factors were documented the most conservative score was taken. The minimum 
sample size required to detect a relative increase in cancer of 50% from a statistically conservative base-
line of 50% among the unexposed was calculated at different powers (with a significance level of 5%) 
using the Fleiss method within Epi Info. Different thresholds were set for cohort/cross-sectional studies 
and (unmatched) case-control studies. Conservatively, a ratio of one to one between exposure strata was 
assumed, as well as only two strata. This criteria was scored from 0 (<70% power) to 5 (>99% power). 
We pragmatically defined a minimal confounder set as age, sex and ethnicity. Three reviewers undertook 
the assessment, with at least 10% overlap. Discrepancies were resolved by consensus.
Data synthesis
Due to between-study heterogeneity, the findings of the included publications were narratively synthe-
sised by theme.
Bakkalci et al.
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Ethics approval
As a systematic review of previously published data, this work did not require ethical approval.
RESULTS
Search results and included studies
After de-duplication, 5373 hits were retrieved by the lymphomas search and 2823 by the carcinomas 
search (Figure 1). This was reduced to 229 and 260 hits, respectively, after title and abstract screening. 
271 papers were extracted, including those identified through snowballing: two on EBV-associated BL, 
24 on EBV-associated HL, one on EBV-associated GC and 244 on NPC (Table S1 in the Online Supple-
mentary Document). All BL, HL and GC publications used case-control designs (although one of the HL 
papers also contained a reconstructed cohort) and 227/244 (93.0%) of those for NPC. Papers analysed 
populations ranging in size between 11 and hundreds of thousands (longitudinal studies). The majority 
of NPC analyses were undertaken in China, GC and HL papers in Europe and the Americas, and BL pa-
pers in Africa (Figure 2).
Quality assessment of included studies
In the overall quality assessment, 32/271 (11.8%) of publications were very under-powered, with a score 
of zero or one, ie, less than 80% power (Table S2 in the Online Supplementary Document). An assess-
ment of power could not be undertaken for eight publications. All of the BL and GC publications scored 
zero for power. 15/24 (62.5%) of HL publications and 208/244 (85.2%) NPC publications had a sample 
size sufficient for 90% power or above.
171/271 (63.1%) analyses were undertaken using appropriate statistical methods eg, conditional re-
gression for individually matched studies; 65/271 (24.0%) adjusted for the minimal confounder set. 
Figure 1. Flowcharts of extraction for systematic review. Panel A. EBV-associated Hodgkin’s and Burkitt’s lymphomas. Panel B. 
EBV-associated nasopharyngeal carcinoma and gastric carcinoma. EBV – Epstein Barr virus.
Risk factors for Epstein Barr virus-associated cancers
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Across the publications, none were thought to be 
at high risk for observer bias for the outcome, but 
the potential for recall bias was higher (85/271, 
31.4%), with exceptions being studies of genet-
ic risk factors.
Risk factors for Burkitt’s lymphoma
Two publications met our inclusion criteria for 
EBV-associated BL. Both were undertaken on the 
same population in Uganda in the 1970s. They 
examined infection and clinical factors, specifi-
cally anti-EBV antibody load prior to cancer di-
agnosis (anti-viral capsid antigen [VCA], anti-ear-
ly antigen [EA] and anti-EBV nuclear antigen 
[EBNA]) [27,28]. Only levels of anti-VCA were 
found to be associated with the development of 
BL. Both had small sample sizes and largely uti-
lised descriptive statistics.
Risk factors for Hodgkin’s 
lymphoma
Among the 24 EBV-associated HL publications, 
three examined dietary risk factors, 11 infection 
and clinical factors, eight human genetic fac-
tors, and five environmental and non-diet life-
style. Within these publications, 21 represent-
ed eight sets of overlapping or identical study 
populations (and one did not have enough infor-
mation to classify) [29]: one set from Denmark 
and Sweden [30-34]; one from the Netherlands 
[30,34-37]; three from the UK (England [38,39], 
England [30,34,40,41], England and Scotland) 
[30,34,36,41,42]; two from the USA (Connecti-
cut and Massachusetts [43-45]; California [46-
48]); and one from Canada, Puerto Rico and the 
USA [49,50].
Of the papers partially or totally examining diet 
as a risk factor for HL (Table 1), one looked at 
dietary patterns [43], one alcohol [38], and one 
dietary fats [44]. None of the papers found any 
statistically associated risk factors. Two of these 
publications used substantially overlapping study 
populations [43,44]. Due to the retrospective col-
lection of dietary information, recall bias may 
have been an issue.
Within the infection and clinical factors publica-
tions, three from Europe provided an indication 
that personal infectious mononucleosis (IM) may 
be a risk factor for HL (Table 2) [32,40,42]. Al-
though the two publications from the Americas 
had a high degree of uncertainty (confidence in-
tervals (CI) crossed the null), the reported effect 
estimates were somewhat suggestive of risk for ei-
ther personal or familial IM [47,49]. Importantly, 
all exposure data was self-reported.
Figure 2. Global distribution of extracted publications. Dots represent the 
number of publications reporting data from a particular setting, where 
reported. One publication may have studied participants in multiple set-
tings. Map taken from http://www.freeworldmaps.net/outline/maps/world-
map-outline.gif. Panel A. Burkitt’s lymphoma. Panel B. Hodgkin’s lym-
phoma. Panel C. gastric carcinoma. Panel D. nasopharyngeal carcinoma 
(excluding the global study by Shield et al.) [26].
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Three publications examined the impact of childhood infections. Using a combined variable, Glaser et al. 
found that measles, mumps or rubella may be protective against HL diagnosed in younger patients aged 
19-44 years [47]. When these factors were considered individually CIs crossed the null, but the effect 
estimates tended in the same direction. In older adolescents and young adults, Alexander et al. demon-
strated that two or more infections (measles, mumps, chicken pox, pertussis) were protective without 
examining each infection individually [40]. Within Linabery et al. (children and adolescents), the direc-
tion of effect was protective for mumps, neutral for measles and in favour of risk for rubella (all with CIs 
that crossed the null), but Strep or sore throat/Scarlet fever/Tonsillitis as a combined variable was associ-
ated with greater HL risk and likely contributed strongly to overall findings for infections [49]. Again, all 
exposure data was self-reported. Another publication documented a potential association with cytomeg-
alovirus (CMV) serostatus, but minimal information was available as it was a conference abstract [51].
Two papers examined the impact of autoimmune and allergic conditions on the risk of HL [33,49]. Al-
though each found specific risk factors among the autoimmune conditions (eg, personal rheumatoid 
arthritis, parental autoimmune conditions), the evidence was not consistent. Neither scored higher for 
quality than the other.
Table 1. Summary of dietary factors associated with Hodgkin’s lymphoma
Potential risk factor summary of results
Alcohol No association [38]
Dietary patterns (“vegetable”, “high meat”, “fruit/low-fat dairy”, “desserts/sweets”) No association [43]
Dietary fats (total fat intake; fat subtypes) No association [44] 
Table 2. Summary of infection and clinical factors associated with Hodgkin’s lymphoma
Potential risk factor summary of results
Infection:
Childhood infections (not IM)
Two or more infections (measles, mumps, chicken pox, pertussis, rubella) associated with re-
duced risk [40]
Increased risk associated with Strep or sore throat/scarlet fever/tonsillitis, infections in siblings. 
Other personal infections also considered [49]
Measles, mumps, rubella (as a single variable, but not individually) – potentially protective [47]
Measles, mumps, rubella in older adult patients and chicken pox across all age groups – no as-
sociation found [47]
IM (personal)
Personal IM associated with increased risk (across all ages and in younger adults alone; associ-
ation not seen in older adults alone) [32]
Personal IM associated with increased risk [40]
Personal IM associated with increased risk [42]
Personal IM – no association found [47,49]
IM (familial) Familial IM – no association found [42,47]
IM in siblings – no association found [49]
CMV CMV seropositivity associated with increased risk [51]
Other clinical:
Autoimmune diseases and allergies
Rheumatoid arthritis associated with increased risk. Other autoimmune and allergic conditions 
also examined [33]
Autoimmune conditions in parents associated with increased risk. Personal autoimmune or al-
lergic conditions, autoimmune conditions and allergies in siblings, allergies in parents – no as-
sociation [49]
BMI, weight, height No association (BMI) [39]
Higher weight and BMI associated with protection [45]
No association [48]
Physical activity Participating in (strenuous) physical activity as an adult associated with protection [48]
Family history of cancer Earlier age of cancer onset among family members may be associated with an increased risk. 
Different types of tumour examined [50]
BMI – body mass index, CMV – cytomegalovirus, IM – infectious mononucleosis
Risk factors for Epstein Barr virus-associated cancers
www.jogh.org •  doi: 10.7189/jogh.10.010405 7 June 2020  •  Vol. 10 No. 1 •  010405
V
IE
W
PO
IN
TS
PA
PE
RS
A second publication by Linabery et al., using an overlapping population to their infection, autoimmune 
and allergy study [49], examined the impact of family cancer history, but found no clear associations [50].
Body mass index (BMI), weight, height and measures of physical activity were examined as risk factors 
by three publications [39,45,48]. Physical activity as an adult was associated with protection from HL. 
Two papers documented no BMI association and one found that higher BMI/weight was protective. The 
direction of effect was not associated with the quality of the evidence.
Of the eight publications that examined the human genetic factors associated with EBV-associated HL, 
six focussed on human leukocyte antigens (HLA), with one additionally looking at tumour necrosis fac-
tor (TNF) α and β (Table 3) [29,30,35-37,41]. One examined Killer-cell immunoglobulin-like receptors 
(KIRs) [52] and one was a general genetics publication [34].
Table 3. Summary of human genetic factors associated with Hodgkin’s lymphoma
Potential risk factor summary of results
HLA and associated genes:
HLA-A A*01 associated with increased risk, A*02 with decreased risk [36]
A*01:01 associated with increased risk [41]
HLA-B B*08:01 associated with increased risk [41]
B*07 and B*08 no association [29]
HLA region Locus D6S265 allele 126 and locus D6S510 allele 284 heterozygotes and homozygotes (both HLA class 
I) associated with HL risk in a classic association analysis. (Other, weaker, associations also found.) 
Association lost when haplotype sharing statistic analysed [35]. Later narrowed down as above [36].
HLA class I associated through seven SNPs – rs2530388, rs3823352, rs2256543, rs4713276, 
rs2523972, rs6457110, rs2517749 [37]. Later narrowed down as above [36].
C*07:01 and DRB1*03:01 associated with increased risk [41]
Genome-wide association study: rs6904029 (HCG9) associated with decreased risk or rs2734986 
(HLA-G) associated with increased risk [34]
rs6457715, near HLA-DPB1, associated with increased risk [30]
Cytokines and chemokines:
TNFA, TNFB No association [35]
Other immune-related:
KIR No clear association [52]
HL – Hodgkin’s lymphoma, HLA – human leukocyte antigen, KIR – killer-cell immunoglobulin-like receptors, SNP – single nucleotide polymorphism, 
TNF – tumour necrosis factor
Among the HLA papers, the evidence was balanced in favour of a HLA-A association, particularly an in-
creased risk with the HLA-A*01 serotype group. Three publications represented a gradual narrowing 
down to A*01 [35-37]. For B alleles, the evidence was contradictory. Various other alleles and loci were 
also associated.
Of the publications examining environmental and non-diet lifestyle factors, three looked at smoking as a 
risk factor for HL (Table 4) [31,38,46]. All three provided evidence supportive of an association between 
current smoking and HL (and two of ever having smoked and HL), including from Willet et al., which 
had previously found no association with alcohol.[38] More detailed breakdowns of smoking status were 
less clear, however. There was a risk of recall bias in all of the analyses and only one adjusted for all of our 
a priori confounders, but analysis choices were deemed appropriate throughout.
Within the Glaser et al. and Hjlagrim et al. IM publications, environmental factors during childhood were 
also documented [32,47]. Among younger adult patients only (19-44 years; other grouping 45-79 years) 
in Glaser et al., sharing a bedroom and being an older sibling was associated with reduced risk. Similar-
ly, Hjalgrim et al. noted that having more younger siblings was protective across all ages, but when the 
population was broken down by age the association was only observed among those 18-44 years (ie, not 
in those 45-74 years old). These papers performed similarly in terms of quality to their previously doc-
umented counterparts.
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Risk factors for gastric carcinoma
One publication met our inclusion criteria for EBV-associated GC. In American men of Japanese ances-
try, Levine et al. examined infection and clinical factors for GC, specifically anti-EBV antibody load prior 
to cancer being diagnosed (IgG and IgA anti-VCA, IgG anti-EA and IgG anti-EBNA) [53]. IgG anti-VCA 
was specifically found to be associated with EBV-positive GC vs non-cancer controls. Power was very low 
and the minimal confounder set was not adjusted for.
Risk factors for nasopharyngeal carcinoma
Among the 244 NPC publications, 45 examined dietary risk factors, 50 infection and clinical factors, 
158 human genetic factors, and 56 environmental and non-diet lifestyle. Publications from the same set-
ting and time frame (thus with overlapping populations) were numerous. Two Coghill et al. publications 
were a conference abstract and a manuscript of the same analyses, thus the abstract is excluded from the 
following [54,55].
Among the dietary risk factors papers, there were a series of common factors that were assessed (Table 
5). The first of these was alcohol (often in combination with smoking), where generally the evidence was 
not in favour of involvement [56,58-73].
Salted fish was a second frequently analysed factor, with eleven publications determining it to be a risk 
factor [57,59,64,65,71,77-82], three with some (but not conclusive) evidence of association [83-85], and 
seven as not associated with NPC (although, in four of these, effect estimates trended in the risk factor 
direction) [60,72,76,86-89]. Smoked, cured or dried preserved meats had no consistent association with 
NPC (seven papers) [72,74,76,86-88]. Rancid dairy and other fats were considered to be a risk factor or 
to be potentially associated in all four of the analyses that included them [61,75,91]. Slow cooked soup 
was associated with protection against NPC in two [65,82].
Two papers were in agreement that preserved plums were a risk factor for NPC [84,93]. Broadly, fresh fruit 
and vegetables were deemed protective, as was the consumption of tea in various forms, including herbal.
The infection and clinical papers examined risk factors that fell into eight main categories-EBV serology/
DNA load/genetics, other infections, medical history, medication, oral hygiene, T-cells, and family histo-
ry of NPC or cancer (Table 6).
Overall, anti-EBV antibodies were associated with NPC. Among the seven papers, four documented this 
association with anti-VCA antibodies (three IgA [90,92,94-96], one IgG) [97], one anti-EA (IgA) [94], one 
anti-EA/EBNA-1 [95], two anti-EBV deoxyribonuclease [92,96], and one suggested that anti-gp350 was 
protective [55]. One showed no associations and two that some antibodies were not associated. Where 
stated, all used serum samples for testing.
In terms of medical history, the general trend of evidence was that a history of (chronic) ear nose and/or 
throat conditions was associated with NPC risk, as were herbal medicines. Nasal balms, drops, ointments, 
oils or sprays were generally not associated (five of seven papers).
Table 4. Summary of environmental and non-diet lifestyle factors associated with Hodgkin’s lymphoma
Potential risk factor summary of results
Smoking Having ever smoked and being a current smoker associated with increased risk [38]
Having ever smoked and current smoking associated [31]
Current smoking associated [46]
Years smoked, pack years and years since stopped smoking – no association [38]
Age at initiation of smoking, duration, intensity, cumulative exposure, time since cessation – not 
associated [31]
Having ever smoked, intensity, duration, age at initiation, years since cessation and childhood ex-
posure – no association [46]
Childhood environmental factors Numbers of younger siblings associated with protection [32]
Being an older sibling potentially protective among younger adult patients [47]
Number of older siblings – no association [32]
Childhood household size no association [47]
Bedroom sharing associated with reduced risk among younger adult patients [47]
Persons per room, attendance at kindergarten, mother’s age at birth, personal and parental edu-
cation levels – no association [32]
Number of playmates – no association [47]
Risk factors for Epstein Barr virus-associated cancers
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Table 5. Summary of dietary factors associated with nasopharyngeal carcinoma
Potential risk factor summary of results
Alcohol Risk factor [78] [S1,S2]
Potentially associated [79] [S3]
No overall association [56, 58-73]
Results inconclusive [S4]
Result undocumented [S5]
Dairy:
Rancid dairy products Rancid butter risk factor [61,75]
Rancid butter potential association [91]
Other dairy products Milk protective [S5,S6]
Milk no association [61,86]
Butter no association [61]
Eggs protective [61] [S6]
Eggs no association [86]
Salted (duck) eggs (particular time points) risk factor [79,83]
No association [91]
Fish and shellfish:
Salted fish Risk factor [57,59,64,65,71,77-82]
Inconclusive [83-85]
No association [60,72,76,86-89]
Other preserved fish Protective [75]
Dried fish results inconclusive [83]
No association [87]
Fermented fish (sauce) – no association [60,72,84]
Other fish/shellfish Shrimp protective [79]
No association [87]
Fresh fish protective [S6]
Fresh fish potentially protective [86]
Fresh fish and other seafood  – no association [86]
Deep sea fish protective [S5]
Meat:
Smoked, cured, dried, salted preserved meat Risk factor [58] [S1]
Risk factor, but not consistent [75,82]
No association [74,76,86-88]
Quaddid risk factor [S7]
Fermented pork no association [72]
Salted meat no association [72]
Other meat Fresh meat (pork/beef liver) risk factor [79]
Red meat risk factor [68]
Chicken risk factor [S7]
Chicken protective [91]
Fried meat – inconclusive association [61]
Sheep’s tail fat no association [S7]
Merguez, khelli no association [75]
Fresh meat no association [86]
Processed meat no association [S6]
Sausage no association [72]
Other salted products Salt-cured food risk factor [68]
Salted vegetables risk factor (at least in adulthood) [79,82]
Salted and dried tomatoes or salted or brined peppers risk factor [61]
Other salty foods – inconclusive association [61]
Salted vegetables no association [72]
Salted mustard greens – inconclusive association [83]
Salted roots no association [79]
Other fermented and preserved foods Fermented pastes risk factor [82]
Fermented black bean paste and fermented soy bean paste no association [83]
Fermented foods no association [S1]
Fermented soy bean products associated [92]
Fermented soybean products no association [88]
Fermented and salted vegetables no association [72]
Preserved vegetables (potential) risk factor [57,65,72]
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Potential risk factor summary of results
Preserved plums risk factor [84,93]
Preserved vegetables generally risk factor (although salted vegetables and picked Chi-
nese cabbage protective) [93]
Preserved vegetables no association [86,88]
Preserved fruit no association [79]
Pickled vegetables (and fungus on pickles) risk factor [S7]
Mouldy bean curd no association [84]
Vegetables, beans and fruit Chung choi not consistently associated, could be risk factor [83]
Fresh fruits in childhood protective [82]
Fresh fruit associated protective [61]
Fresh fruit and vegetables protective [79]
Fresh green vegetables protective, others no association [84]
Fruit and vegetables protective [68] [S6]
Leafy vegetables protective [85]
Dark vegetables and fresh fruit protective [S5]
Grapes protective [91,93]
Non-preserved fruits and vegetables generally protective [93]
Cooked vegetables and citrus fruits not consistently associated [75]
Fresh fruit and vegetables (including green and leafy) no association [74,86]
Servings per week of fruit and vegetables no association [88]
Carrots no association [64,86,91]
Other:
Coffee No association [73,86] [S6]
Tea Herbal tea risk factor [85]
Green tea protective [86]
Herbal tea protective [82]
Protective [65,73] [S4,S6]
Inconclusive association [61]
Black, Oolong tea no association [86]
Slow cooked soup Protective [65,82]
Dietary nutrients Folate, vitamin B6, protective; vitamin B12, methionine no association [S8]
Vitamin A, Vitamin C, tocopherol no association [86]
Beta carotene and vitamin C no association [74]
Foods containing nitrosamines Inconclusive association across all foods [88]
Preserves and condiments In childhood risk factor [S7]
Regular spicy sauce consumption generally risk factor [61]
No association [75,91]
Other Irregular meals risk factor [61]
Adult diet on weaning risk factor [S7]
Rancid sheep fat risk factor [75]
Melon seeds risk factor [85]
Sugary, dried or salted snacks, risk factor [61]
Food additives risk factor [S9]
White bread risk factor [S9]
Lentils protective [91]
Corn bread protective [S9]
Margarine and olive oil protective [S9]
M’hammas no association [S7]
Potatoes no association [91]
Grains no association [61]
Monosodium glutamate no association [85]
Non-dairy oils and fats no association, unless salted [61]
Olives no association [75,87]
Protein, fat, carbohydrate, sodium intake, soybean milk no association [86]
Olives inconclusive [61]
French fries – inconclusive association [61]
General diet – results unclear [95]
*References marked with letter S are available in the Online Supplementary Document.
Table 5. Continued
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Table 6. Summary of infection and clinical factors associated with nasopharyngeal carcinoma
Potential risk factor summary of results
Infection:
EBV serology Higher titres associated risk factor [92,94-97]
Lower anti-gp350 levels associated risk factor. Potential interaction with IgA anti-EB-
NA-1 [55]
Stable, fluctuating or ascending IgA anti-VCA risk factor [90]
IgA anti-VCA, anti-EA, anti-EBNA not associated [97]
IgA/IgG anti-VCA, IgA/IgG anti-EA, anti-EBNA not associated [S10]
Anti-gH/gL not associated [55]
Other infections CMV, HSV, VZV no association [S11]
SV40 – no association[S12]
Core antigen of HBV associated with higher risk, other antigens/antibodies no associ-
ation [S13]
IM – potential association, depending upon how recent exposure was [S14]
IM – no association [S3]
Malaria – association not consistent [63]
Other clinical:
Medical history Allergic rhinitis associated risk factor [S15]
Acute and/or chronic rhinosinusitis risk factor [S9,S16]
Paranasal sinusitis risk factor [S17]
Sinusitis potential risk factor [92]
(Chronic) ear, nose (and throat) conditions risk factor [60,62,73] [S18]
(Chronic) ear and nose diseases – inconclusive [83]
Ear, nose and throat conditions – no association [64]
Hayfever, tonsillectomy, heart disease, diabetes, cold sores, canker sores no associa-
tion [73]
Nasal polyps, childhood radiation treatment no association[S3]
Result undocumented [S5]
Medication Herbal medicines risk factor [S17,S19-S21]
Herbal medicines – no association [S22]
Home remedies in childhood risk factor [S7]
Nasal balms, drops or oils – risk factor [58] [S17]
Nasal balms, drops, ointments, oils or sprays – no association [59,64,83] [S3,S22]
Nasal balms or oils – unclear [S21]
Oral hygiene Frequent brushing, fewer filled/decayed teeth protective [61] [S23]
T-cells
Higher proportions of LMP-2 specific cytotoxic T-cells and CD4+/CD25+ T-cells risk 
factor [S24]
Family history of NPC Risk factor [57,63,65,76,78] [S5,S18,S25-S31]
Inconclusive evidence [60,92,95]
No association [62,77]
Results not clearly presented [64]
Family history of cancer Risk factor [69,78,93] [S9,S27]
No association [S29,S30]
CD – cluster of differentiation, CMV – cytomegalovirus, EA – early antigen, EBNA – Epstein Barr virus nuclear antigen, EBV – Ep-
stein Barr virus, gp – glycoprotein, HBV – hepatitis B virus, HSV – herpes simplex virus, Ig – immunoglobulin, IM – infectious 
mononucleosis, LMP – latent membrane protein, NPC – nasopharyngeal carcinoma, SNP – single nucleotide polymorphism, SV40 
– simian virus 40, VCA – viral capsid antigen, VZV – varicella zoster virus
*References marked with letter S are available in the Online Supplementary Document.
Twenty publications analysed whether a family history of NPC was associated with personal risk, with 
the balance of evidence on the side of this being a risk factor (15 publications), in line with the genetic 
evidence presented in Table 7. Three other publications contained effect estimates that trended in the 
same direction. Among the 15, only one adjusted for genetic factors in the analysis; four others adjusted 
for other shared factors eg, diet. Five of the seven analyses examining whether family history of cancer 
as a whole was associated with personal NPC also had positive results; the likelihood and strength of the 
associations could be linked to the setting in which this work was undertaken, ie, how large a propor-
tion of all cancer cases are due to NPC, although the studies were geographically confined within Asia.
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Table 7. Summary of human genetic factors associated with nasopharyngeal carcinoma
Potential risk factor references
Angiogenesis: 
VEGF [S32,S33]
Apoptosis
FAS/FAS-L [S34-S36]
Red blood cell antigens [61] [S37-S40]
Cell cycle, growth and differentiation:
CCND1 [S41,S42]
EGF, EGFR [S43]
MDM2 [S44-S46]
TP53 [S45,S47-S51]
Cellular adhesion:
CD44 [S52]
CDH1 [S53]
MMP [S54,S55]
Cellular chaperones:
HSP-70 [S56]
Cytokines and chemokines:
IFN-A [S48]
IFN-G [S57,S58]
IFN-GR1 [S59]
IL-1A/B [S59-S61]
IL-1RN [S59,S62]
IL-2 [S63]
IL-4RA [S59]
IL-8 [S58,S64,S65]
IL-10 [S57,S59,S66-68]
IL-12 [S69,S70]
IL-16 [S71]
IL-18 [S66,S72,S73]
IL-27 [S70]
TGFB [S74,S75]
TNFA [S56,S76,S77]
DNA damage and repair:
General [S78,S79]
BPIFA1 [S80]
ERCC1 [S81]
ERCC2 [S82]
hOGG1 [S83]
NBS1 [S84]
XPC [S85]
XRCC1 [S82,S83,S86,S87]
XRCC3 [S82,S88]
HLA and associated genes:
HCGA9 [S59]
HLA region/type [S38,S40,S89-S115]
HLA-A [S59,S116-S118]
*References marked with letter S are available in the Online Supplementary Document.
Potential risk factor references
HLA-DQ [S119,S120]
HLA-DR [S120]
HLA-E [S121-S123]
HLA-G [S124]
MICA [S125,S126]
TAP1 [S127,S128]
Inflammation:
COX-2 [S129]
MAPKAPK2 [S130]
Metabolism:
CYP1A1 [S1,S131]
CYP2A6 [S1]
CYP2E1 [89] [S1,S132-S137]
GSTM1 [S1,S131,S138-S147]
GSTP1 [S131,S133,S144]
GSTT1 [S1,S131,S138, S140-S142,S144,S147]
MPO [S133]
MTHFR [S148]
NAT2 [S131,S138]
NQO1 [S133]
MicroRNAs:
MIR34 [S149]
Multiple [S150]
Other immune-related:
CR2 [S151-S153]
CTLA4 [S154]
DC SIGN [S155]
IGK [S156]
KIR [S90,S96,S157]
PIGR [S152,S158,S159]
TLR3 [S160]
TLR4 [S161]
TLR10 [S162]
Other:
ACE [S163]
BPIFA1 (PLUNC) [S164]
CAV-1 [S165]
DLC-1 [S166]
IKB [S167]
MAP2K4 [S168]
N4BP2 [S169]
NFKB [S167,S170]
VDR [S171]
Genome wide-association study/
other screening approaches
[57,68,72] 
[S142,S172-S182]
Human genetic risk factors for NPC have been thoroughly reviewed elsewhere, particularly by Hildesheim 
et al. [9]. Table 7 thus briefly documents the publications on such factors, grouped by the genes of in-
terest. Publications were generally of reasonable quality, with no risk of recall bias for the genetics com-
ponent of the work. 137/158 (86.7%) had sample sizes that met our criteria for 90% power or more and 
90/158 (57.0%) clearly documented recruiting individuals for both exposure arms from the same popu-
lation. 60/158 (38.0%) were not assessed as having used appropriate statistical tests (usually due to the 
type of matching used).
Among the environmental and non-dietary risk factors papers, smoking and exposure to dust, smoke 
and fumes in both home and occupational environments, and socioeconomic status were common fac-
Risk factors for Epstein Barr virus-associated cancers
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tors to analyse (Table 8). Both passive and personal smoking was analysed by a series of papers, with a 
wide variety of findings. Twelve publications found smoking to be a risk factor, an additional two report-
ed a potential association and fifteen inconclusive or unclear associations. Nine publications found no 
evidence for an association.
Table 8. Summary of environmental and non-diet lifestyle factors associated with nasopharyngeal carcinoma
Potential risk factor summary of results
Smoking/tobacco Risk factor (passive or personal) [56,57,60,61,65,69,72] [S2,S3,S5,S9,S21]
Potential association [78] [S30]
Passive or personal smoking no association [66-68,70,71,89] [S1,S18,S183]
Results inconclusive or association unclear [58,59,62-64,73,76,83,92,93,95,96] [S17,S22,S26,S184]
Cannabis and other drugs Cannabis – unclear association [67]
Betel nuts – no association [58,72,89]
Betel nuts – result undocumented [S5]
Occupational exposures:
Wood dust and wood Wood dust risk factor [60] [S184,S185]
Wood dust – no clear associations [S186]
Wood – no association [59,89]
Wood cutting no association [71]
Smoke, fumes and dust Inhalation of smoke and dust risk factor [59]
Smoke, quarry, road or other dust risk factor [59]
Fumes and smoke risk factors [73]
Dust/exhaust risk factors [S187]
Products of combustion risk factor if lengthy exposure [S18]
Construction dust no association [59]
Dust and/or fumes, smoke no association [64,73] [S18,S184]
Wool and synthetic fibre dust no association [S188]
Formaldehyde and other  
chemicals
Chlorophenols risk factor [S189]
Chemicals risk factors [73]
Chemicals no association [S184]
Chemical fumes inconclusive [64]
Formaldehyde – no clear association [S186,S187]
Formaldehyde no association [S184,S185]
Bleaching agents, dyes and endotoxin no association[S188]
Solvents Solvents no association [S185,S188]
Solvents – impact inconclusive [76]
Heat Potential risk factor [73]
No association [S184]
Ventilation Poor ventilation – results unclear [S21]
No association [S22]
Overall occupation Agricultural work potential risk factor [71]
Occupational hazards risk factor [68]
Occupation no association [58] [S17,S190]
Occupation – result undocumented [S5]
Occupational exposure to cotton dust, inks and potentially acids, bases and caustics risk factors [S188]
Home environment:
Wood dust and wood Wood fuel risk factor [76,85]
Smoke and fumes
Exposure to cooking fumes through having no separate kitchen or a range without a chimney risk fac-
tor [93]
Poor ventilation risk factor [85] [S1,S17]
Poor ventilation no association [58]
Domestic fumes – no consistent association [67]
Soot and cooking fuel no association [58]
Water Reservoir sourced water protective [91]
General dust and smoke General smoke exposure risk factor [S1]
General dust exposure no association [S1]
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Potential risk factor summary of results
Family structure:
Sibship size (particularly older siblings) risk factor; birth interval, maternal and paternal age no asso-
ciation [S191]
Birth order – coming later is protective [S192]
Marital status – no consistent association[63]
Age:
Age – rate increases with age  [S193]
Age – increases into 30-50 year age groups [S17]
Age – more NPC than expected in individuals aged 30-39 [S104]
Age – peak in late adolescence/early adulthood (15-24) and then later in life (65-79 years) [S195]
Sex:
Sex – more NPC in men [S17,S193,S194]
Geographic region and ethnicity:
Country – eastern and southeastern Asian are the highest rate regions; China, Malaysia and Singapore 
countries of note [26]
Ethnicity – rates higher in individuals with Native American ancestry than White or Hispanic [S196]
Ethnicity – in individuals with White and Black ancestry higher rates than Chinese [S193]
Ethnicity – mainland Chinese vs Taiwanese, association with NPC [S21]
Ethnicity – higher risk in mainlanders than in Taiwanese [S17]
Immigration – immigrants have higher NPC rates, particularly if they originate from North Africa, 
Southeast Asia and Asian Arab countries [S197]
Socio-demographic:
Socioeconomic status – higher is a risk factor [58,85]
Education – higher levels protective [60] [S3]
Education – no consistent association [63]
Education – no association [S190]
NPC – nasopharyngeal carcinoma
*References marked with letter S are available in the Online Supplementary Document.
Table 8. Continued
Broad analyses of the impact of dust, fumes and smoke in occupational settings were inconclusive across 
included papers, however, within the different analyses of dust, wood dust was found to be associated 
in three analyses, but not in a fourth. Other occupational wood exposure was not found to be associat-
ed, but use of wood fuels in the home was found to be a risk factor within two publications. Poor venti-
lation in the workplace was not found to be associated with NPC risk. Within the home, the balance of 
evidence suggested that poor ventilation could be a risk factor. The association with socioeconomic sta-
tus and education was inconsistent.
DISCUSSION
BL, HL, GC and NPC are established as EBV-associated cancers. We present the first systematic review of 
epidemiological studies of risk factors in addition to EBV for the EBV-associated forms of these cancers, with 
an associated quality assessment. The 271 included publications provide a rich overview of our knowledge 
on the causes of EBV-associated BL, HL, GC and NPC. We highlight smoking, IM, and the HLA genetic re-
gion as risk factors for HL and being an older sibling as potentially protective. Rancid dairy products, salted 
fish, anti-EBV antibody and EBV DNA load, history of chronic ear, nose and/or throat conditions, herbal 
medicine use, family history, and genetics are NPC risk factors, as well as potentially smoking. In addition, 
fresh fruit and vegetables, slow cooked soup, and tea consumption are potentially protective against NPC. 
Anti-EBV antibody load was found to be associated with both BL and GC. We thus demonstrate a wider 
range of risk factors for NPC than the other EBV-associated cancers, which could either represent a more 
complex aetiology for NPC, or simply the limited number of publications for the other diseases.
In addition to the extensive array of studies and thus risk factors documented within this review, we note 
that our fundamental understanding of EBV and its associated cancers is underpinned by many important 
Risk factors for Epstein Barr virus-associated cancers
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laboratory and epidemiological studies not captured by our specific and rigorous inclusion criteria [98]. 
Critically, we note the detailed evidence accumulated over decades linking endemic malaria to BL, which 
has been derived largely from settings where the EBV association with BL is robust [99]. Less strongly, 
HLA type, plants in the Euphorbiaceae family, and sociodemographic factors have been suggested to be 
associated with BL [5,100,101]. For GC, inference from studies where EBV status is unknown or neg-
ative is more problematic, as the EBV-associated form of the disease represents a distinct subtype with 
markedly different genomic, immunologic and pathological features [102], many of which have direct 
therapeutic relevance [103].
The major strength of this work is its systematic approach to examining published risk factors for EBV-as-
sociated cancers, including a quality assessment and mapping of the available literature. The global and 
temporal scope of our review allows a wide-reaching consolidation of the literature to date, as well as an 
identification of our knowledge gaps and targeting of future studies. As to its limitations, many of the 
NPC papers (particularly genetics studies) were only captured during the snowballing process, likely due 
to our decision to follow the STROBE guidelines for indexing when choosing our search terms. We ex-
cluded studies of genetic factors where samples were taken from cancer tissues, due to concerns about 
malignancy-induced genetic changes. This may, however, have excluded some genetics studies of loci 
that are unlikely to have been mutated in a cancerous cell. It should be noted that, where we document 
that a publication provides no evidence of an association, this does not mean that the converse is true; 
some studies were simply under-powered, thus confidence intervals were wide and estimates statistical-
ly uncertain. Our sample size calculations did not consider the implications of matching. We only docu-
mented analyses answering the declared aims or hypotheses of a publication; while post hoc exploratory 
data analyses can provide valuable insights, they require formal validation by subsequent studies and can 
sometimes arise due to data dredging [104].
Regarding the methodological quality of the included publications, we note several common features. 
Testing of multiple factors was common, increasing the likelihood of chance findings. Slightly over a third 
of publications used inappropriate statistical methods and only a quarter adjusted for our pragmatically 
minimal confounder set of age, ethnicity and sex. We acknowledge, however, that studies from certain 
settings would have recruited from ethnically homogenous populations, removing the need to control 
for ethnicity. Particular care should be taken interpreting the findings of dietary and environmental fac-
tor studies that do not adjust for upstream socioeconomic determinants of these factors and generally of 
recall bias. A few publications only presented results for factors positively associated with cancer.
As this review was specifically one of EBV-associated forms of our chosen cancers, we were limited by the 
number of studies that did not report EBV status. For GC, this reflects the relatively recent documenta-
tion of GC’s EBV-association and the fact that histological samples are not tested for the virus as standard. 
Without such testing, future meta-analyses will be substantially hampered. The close association between 
BL and EBV in endemic areas means that we could have included all publications from these regions re-
gardless of EBV tumour status, however we opted for a consistent approach per tumour.
The major implications of our findings for public health are as follows. First, some of the critical risk and 
protective factors documented are modifiable eg, dietary elements, such as the consumption of rancid 
dairy products. These present opportunities for governmental interventions. Second, risk profiles can be 
built from these data for use as screening tools in areas of high cancer incidence. Third, our thorough 
documentation of the literature to date provides a signpost for future studies a) examining promising, 
but not fully proven, risk or protective factors in a broader span of geographical locations and b) to en-
sure that causal networks can be thoroughly mapped and thus confounders appropriately adjusted for 
[105]. Finally, it is importantly to reflect on the fact that the EBV-associated forms of certain cancers, eg, 
GC- differ from the non-EBV-associated forms. Thus reviews such as ours, where EBV-associated forms 
are considered separately, are critical to order to direct control efforts.
CONCLUSIONS
We document 271 epidemiological publications on risk factors in addition to EBV for the EBV-associated 
forms of BL, GC, HL and NPC; the majority focussed on NPC. The quality of the available evidence was 
variable. The aetiology of EBV-associated cancers likely results from a complex intersection of genetic, 
clinical and dietary factors, which are difficult to pull apart through observational studies. A more stra-
tegic approach to building the evidence base should be undertaken with large, well-designed studies, in 
order to harmonise and clarify the evidence, particularly for GC and BL.
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